A STUDY ON EVALUATION OF THE EFFICACY OF LAMOTRIGINE AS ADD-ON TREATMENT IN RESISTANT TYPE OF PRIMARILY GENERALIZED TONIC-CLONIC EPILEPSY IN BURDWAN MEDICAL COLLEGE, WEST BENGAL, INDIA
Background: Treatment of resistant type of Primarily Generalized Tonic-Clonic (PGTC) Epilepsy is a difficult area. In different parts of the world lots of studies conducted on this area with varying results. In this perspective, there was need of this study, especially in this part of the country, Burdwan Medical College, West Bengal, India, where previously there was no such study.
Objective: The objective of my study was to evaluate the efficacy of Lamotrigine as Add-On Treatment in Primarily Generalized Tonic-Clonic Epilepsy.
Materials and Methods: 46 resistant type of Primarily Generalized Tonic-Clonic Epileptic patients were randomly recruited from the Out Patient Department (OPD), Burdwan Medical College& Hospital, West Bengal. The patients were taking either Valproic acid or Carbamazepine or combination of Valproic acid & Carbamazepine. All were placed on oral Lamotrigine in addition to their exiting antiepileptic drugs. Efficacy was measured subsequently by efficacy measuring scale.
Results: After add-on Lamotrigine 50% responder rate was 39.129%. 5 patients (10.869%) rendered seizure free. The reduction of mean seizure frequency was 47.129% and response ratio was -0.32 Â± 0.249 (mean Â± SD). Add-on lamotrigine cause significant reduction (p < 0.05) of seizure frequency from the baseline value and desirable effects were seen irrespective of patients whether taking valproic acid or carbamazepine or combination of valproic acid& carbamazepine. CONCLUSION: Add-on lamotrigine was efficacious in resistant type of Primarily Generalized Tonic- Clonic Epilepsy, in this tertiary care teaching hospital.
Key Words: Epilepsy, Primarily, Generalized, Tonic-Clonic, Resistant
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).